Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Conditions:   Anemia, Sickle Cell;   Complex and Transfusion-dependent Hemoglobinopathies;   Thalassemia;   Alpha or Beta Thalassemia Major;   Diamond-Blackfan Anemia;   Bone Marrow Failure Syndromes Characterized by Severe Chronic AnemiaIntervention:   Device: Enriched Hematopoetic Stem Cell TransplantationSponsors:   University of Louisville;   Duke UniversitySuspended - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2011 Category: Research Source Type: clinical trials

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Conditions:   Anemia, Sickle Cell;   Complex and Transfusion-dependent Hemoglobinopathies;   Thalassemia;   Alpha or Beta Thalassemia Major;   Diamond-Blackfan Anemia;   Bone Marrow Failure Syndromes Characterized by Severe Chronic AnemiaIntervention:   Device: Enriched Hematopoetic Stem Cell TransplantationSponsors:   University of Louisville;   Duke UniversityActive, not recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2011 Category: Research Source Type: clinical trials

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Conditions:   Anemia, Sickle Cell;   Complex and Transfusion-dependent Hemoglobinopathies;   Thalassemia;   Alpha or Beta Thalassemia Major;   Diamond-Blackfan Anemia;   Bone Marrow Failure Syndromes Characterized by Severe Chronic AnemiaIntervention:   Device: Enriched Hematopoetic Stem Cell TransplantationSponsors:   University of Louisville;   University of Louisville;   Duke UniversityActive, not recruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2011 Category: Research Source Type: clinical trials